Dr. R. Rox Anderson, MD, PHD - Scientific Co-founder of Follica

Dr. R. Rox Anderson serves as a Professor of Dermatology, Harvard Medical School and Adjunct Professor of Health Sciences and Technology at MIT. He leads a research group at the Wellman Laboratories of Photomedicine. Dr. Anderson is the Co-founder and Scientific Advisor of Seventh Sense Biosystems, Inc.  Dr. Anderson is an Advisor of PureTech Health. He Co-founded Follica, Inc. in 2005 and served as the Chairman of the Scientific Advisory Board.  He serves as Director of the MGH Laser Center. Dr. Anderson serves as Director of Wellman Center for Photomedicine, Massachusetts General Hospital. He serves as a Member of Medical Advisory Board of Apogee Technology Inc. He is a Co-Founder of Freedom-2, Inc. and serves as its Member of Scientific Advisory Board. He served as a Member of Scientific Advisory Board of Magen BioSciences, Inc. and Solta Medical, Inc. He practices dermatology at Massachusetts General Hospital and teaches at Harvard and MIT. Dr. Anderson conceived and developed many of the non-scarring laser treatments, widely used in medical care. He has also contributed to treatment for vocal cords, kidney stones, glaucoma, heart disease, photodynamic therapy for cancer and acne, and optical diagnostics. Dr. Anderson was a lead inventor for Zeltiq/CoolSculpting, which was recently acquired by Allergan. His research has advanced the basic knowledge of human skin photobiology, drug photosensitization mechanisms, tissue optics, and laser-tissue interactions. His active research areas include diagnostic tissue imaging and spectroscopy, photodynamic therapy, mechanisms of selective laser-tissue interactions, adipose tissue biology and novel therapy for skin disorders. He has authored or co-authored over 250 scientific books and research papers, and 65 issued patents. Dr. Anderson holds a BS in Life Sciences at the Massachusetts Institute of Technology, an MD degree magna cum laude from the joint MIT-Harvard medical program, Health Sciences and Technology and completed residency in Dermatology and research fellowships at Harvard.

Dr. Ken Washenik, MD, PHD - Scientific Advisory Board Member of Follica

Dr. Ken Washenik is President and Chief Medical Director of Bosley Medical Group, and former Chief Executive Officer of Aderans Research Institute, a biotechnology firm involved in researching tissue engineered hair follicle neogenesis and cellular based hair restoration.  Dr. Washenik is the immediate past President and a Board member of the North American Hair Research Society and Vice Chair of the Board of Trustees of the Hair Foundation. He is also on the Board of the International Society of Hair Restoration Surgery and the Cicatricial Alopecia Research Foundation as well as a member of the American Academy of Dermatology and the medical honor society, Alpha Omega Alpha. He is a Diplomate of the American Board of Dermatology and a member of the Dermatological Society of Greater New York and the Los Angeles Metropolitan Dermatological Society.  The former director of the Dermatopharmacology Unit at the New York University School of Medicine, Dr. Washenik continues to serve as a clinical investigator and faculty member in the Department of Dermatology.  Dr. Washenik, a well known national and international lecturer, has presented many seminars on hair growth and loss, dermatopharmacology and dermatology-related issues. His Ph.D. is in Cell Biology and focused on hormone metabolism.  Dr. Washenik has published numerous scientific and medical articles in peer review journals including Endocrinology, Journal of the American Academy of Dermatology, Archives of Dermatology, The Lancet and The New England Journal of Medicine.

Dr. George Cotsarelis, MD - Scientific Co-founder of Follica

 Dr. Cotsarelis serves as an Active Advisor to dermatology companies developing novel  approaches to treating hair loss. He is Milton B. Hartzell Professor in the Department of Dermatology at the University of Pennsylvania. Dr. Cotsarelis serves as the Chairman of Dermatology at the University of Pennsylvania.  Dr. Cotsarelis co-founded Follica, Inc. in 2005 and is the Lead Inventor of Follica's platform technology. Dr. Cotsarelis' research led to the isolation and characterization of the expression pattern of stem cells from the bulge region of the follicle. Dr. Cotsarelis is a pioneer and foremost expert in epithelial stem cell biology. He has published over 40 peer reviewed journal articles and has several issued and pending patents based on his scientific discoveries. He has an active clinical practice at the hospotal affiliated with the University. Dr. Cotsarelis hold an M.D degree.